KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercia...
What macro or health‑system trends could sustain or threaten the continued double‑digit revenue growth trajectory beyond 2025?
Does the company’s increased revenue translate into higher effective earnings per share (EPS) or is it offset by higher R&D or SG&A costs?
What is the expected impact of the raised guidance on institutional and retail demand for KRMD shares?
22 days ago